AstraZeneca advances weight-loss pill to take aim at obesity leaders ○
found
a story from Financial Times ✅ › Financial Times
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Pill from drugmaker would put it into competition with market leaders Novo Nordisk and Eli Lilly